Total Payments
$9,667
2024 Payments
$2,294
Companies
17
Transactions
318
Medicare Patients
123
Medicare Billing
$31,478
Payment Breakdown by Category
Food & Beverage$9,606 (99.4%)
Education$61.16 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,606 | 314 | 99.4% |
| Education | $61.16 | 4 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $1,939 | 76 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,716 | 60 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,633 | 50 | $0 (2024) |
| Alkermes, Inc. | $1,034 | 30 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $867.44 | 31 | $0 (2024) |
| ABBVIE INC. | $648.96 | 28 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $541.88 | 10 | $0 (2024) |
| ITI, Inc. | $531.30 | 13 | $0 (2023) |
| Indivior Inc. | $152.17 | 6 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $133.70 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,294 | 94 | Teva Pharmaceuticals USA, Inc. ($682.51) |
| 2023 | $3,450 | 105 | Otsuka America Pharmaceutical, Inc. ($814.60) |
| 2022 | $2,415 | 78 | Janssen Pharmaceuticals, Inc ($561.38) |
| 2021 | $1,509 | 41 | ITI, Inc. ($275.18) |
All Payment Transactions
318 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $9.15 | General |
| Category: CNS | ||||||
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Neuropsychiatry | ||||||
| 12/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: Central Nervous System | ||||||
| 12/03/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $3.85 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: CNS | ||||||
| 11/20/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CNS | ||||||
| 11/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Central Nervous System | ||||||
| 11/18/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $99.20 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Neurology | ||||||
| 11/12/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: Neuroscience | ||||||
| 11/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $7.68 | General |
| Category: CNS | ||||||
| 11/06/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: Central Nervous System | ||||||
| 10/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: Neuropsychiatry | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $26.90 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Central Nervous System | ||||||
| 10/15/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $30.57 | General |
| Category: Neuroscience | ||||||
| 10/14/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Neuroscience | ||||||
| 09/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $32.33 | General |
| Category: Neuropsychiatry | ||||||
| 08/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: PSYCHIATRY | ||||||
| 08/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Central Nervous System | ||||||
| 08/15/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $32.37 | General |
| Category: Neuroscience | ||||||
| 08/13/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 25 | 174 | $33,843 | $6,160 |
| 2022 | 1 | 36 | 227 | $44,152 | $8,881 |
| 2021 | 1 | 35 | 231 | $44,930 | $9,038 |
| 2020 | 1 | 27 | 228 | $44,346 | $7,400 |
Total Patients
123
Total Services
860
Medicare Billing
$31,478
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 25 | 174 | $33,843 | $6,160 | 18.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 36 | 227 | $44,152 | $8,881 | 20.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 35 | 231 | $44,930 | $9,038 | 20.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 27 | 228 | $44,346 | $7,400 | 16.7% |
About Carl Ivan Denis, PMHNP
Carl Ivan Denis, PMHNP is a Psychiatric/Mental Health healthcare provider based in North Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2017. The National Provider Identifier (NPI) number assigned to this provider is 1700396801.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Carl Ivan Denis, PMHNP has received a total of $9,667 in payments from pharmaceutical and medical device companies, with $2,294 received in 2024. These payments were reported across 318 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($9,606).
As a Medicare-enrolled provider, Denis has provided services to 123 Medicare beneficiaries, totaling 860 services with total Medicare billing of $31,478. Data is available for 4 years (2020–2023), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Location North Miami, FL
- Active Since 10/03/2017
- Last Updated 04/20/2020
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700396801
Products in Payments
- INVEGA SUSTENNA (Drug) $1,398
- ABILIFY MAINTENA (Drug) $907.07
- Austedo XR (Drug) $870.80
- CAPLYTA (Drug) $665.00
- VRAYLAR (Drug) $648.96
- HETLIOZ (Drug) $617.44
- ARISTADA (Drug) $566.47
- INGREZZA (Drug) $541.88
- AUSTEDO (Drug) $518.14
- LYBALVI (Drug) $446.93
- REXULTI (Drug) $436.88
- UZEDY (Drug) $428.16
- SPRAVATO (Drug) $318.25
- ABILIFY ASIMTUFII (Drug) $305.62
- FANAPT (Drug) $250.00
- PERSERIS (Drug) $152.17
- QUVIVIQ (Drug) $132.02
- QELBREE (Drug) $129.79
- AZSTARYS (Drug) $123.80
- COBENFY (Drug) $26.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in North Miami
Antonella Beretta, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $1,121
Psychiatric/Mental Health $1,121
Gladys Lapierre, Ppcnp-Bc/Pmhnp-Bc, PPCNP-BC/PMHNP-BC
Psychiatric/Mental Health — Payments: $479.38
Psychiatric/Mental Health $479.38
Rosie Michel
Psychiatric/Mental Health — Payments: $323.34
Psychiatric/Mental Health $323.34
Ms. Angel Snipes
Psychiatric/Mental Health — Payments: $255.69
Psychiatric/Mental Health $255.69
Rachel Clarke
Psychiatric/Mental Health — Payments: $214.25
Psychiatric/Mental Health $214.25
Ms. Melissa Rousseau, Np, Pmhnp, NP, PMHNP
Psychiatric/Mental Health — Payments: $125.00
Psychiatric/Mental Health $125.00